NEUVAX
Live / Registered — Registered (as of 18 Jan 2022)
What this means for you
Registered since 18 Jan 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87878311
- Registration number
- 6622822
- Mark type
- Stylized text
- Filed
- 16 Apr 2018
- Published for opposition
- 11 Sept 2018
- Registered
- 18 Jan 2022
- Attorney of record
- Neil C. Jones
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and vaccines for the treatment of cancer
Owner
- SELLAS Life Sciences Group, Inc., New York, NY, US
- SELLAS Life Sciences Group, Inc., New York, NY, US
- SELLAS Life Sciences Group, Inc., New York, NY, US
Prosecution history
- 18 Jan 2022 — REGISTERED-PRINCIPAL REGISTER
- 11 Dec 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 10 Dec 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 27 Oct 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 21 Oct 2021 — USE AMENDMENT FILED
- 21 Oct 2021 — TEAS STATEMENT OF USE RECEIVED
- 28 Apr 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Apr 2021 — SOU EXTENSION 5 GRANTED
- 13 Apr 2021 — SOU EXTENSION 5 FILED
- 27 Apr 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 13 Apr 2021 — SOU TEAS EXTENSION RECEIVED
- 05 Nov 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Nov 2020 — SOU EXTENSION 4 GRANTED
- 03 Nov 2020 — SOU EXTENSION 4 FILED
- 03 Nov 2020 — SOU TEAS EXTENSION RECEIVED